TAFINLAR vs TAXOTERE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. TAFINLAR and TAXOTERE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	TAFINLAR	TAXOTERE
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DABRAFENIB MESYLATE	DOCETAXEL
Manufacturer	Novartis	Sanofi Aventis US
Dosage forms	Capsule, Tablet	Injectable
Drug class	—	Microtubule Inhibitor
Boxed warning	None	Boxed warning
Treats	Melanoma	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

tafinlar taxotere

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

DABRAFENIB MESYLATE

DOCETAXEL

Manufacturer

Novartis

Sanofi Aventis US

Dosage forms

Capsule, Tablet

Injectable

Drug class

—

Microtubule Inhibitor

Boxed warning

None

Boxed warning

Treats

Melanoma

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

Frequently asked questions

Which is better-rated, Tafinlar or Taxotere?

Tafinlar and Taxotere are tied at 3.5 out of 5 by our independent rating.

What is the difference between Tafinlar and Taxotere?

Tafinlar contains Dabrafenib Mesylate, while Taxotere contains Docetaxel — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.